...
首页> 外文期刊>European journal of human genetics: EJHG >Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6
【24h】

Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6

机译:早期发病的儿童诊断挑战MSH2和MSH6中的早期发病脱蛋白母细胞母细胞瘤和纯合变种

获取原文
获取原文并翻译 | 示例
           

摘要

Constitutional mismatch repair deficiency (CMMRD) is an autosomal recessively inherited childhood cancer susceptibility syndrome caused by biallelic germline mutations in one of the mismatch repair (MMR) genes. The spectrum of CMMRD-associated tumours is very broad and many CMMRD patients additionally display signposting non-neoplastic features, most frequently cafe-au-lait macules and other pigmentation alterations. We report on a 13-month-old girl suspected of having CMMRD due to a desmoplastic medulloblastoma and a striking skin pigmentation that included multiple cafe-au-lait macules, hypopigmented areas and Mongolian spots. Whole-exome sequencing revealed homozygosity for MSH2 variant p.(Leu92Val) and MSH6 variant p.(Val809del), both variants of uncertain significance (VUS). Immunohistochemical analysis of the tumour tissue showed expression of all four MMR proteins and gMSI testing was negative. However, functional assays demonstrated that the cells of the patient displayed methylation tolerance and ex vivo microsatellite instability, which unequivocally confirmed the diagnosis of CMMRD. Taken together, the results render the MSH2 variant unlikely to be responsible for the phenotype, while they are compatible with MSH6-associated CMMRD. This case illustrates the diagnostic strategy of confirming CMMRD syndrome in patients with VUS.
机译:宪法不匹配修复缺乏(CMMRD)是由双粘性种系突变在失配修复(MMR)基因之一中引起的常染色体遗传性的儿童癌症敏感性综合征。 CMMRD相关肿瘤的频谱非常广泛,许多CMMRD患者另外显示出展示非肿瘤特征,最常咖啡群 - Au-Lait Macules和其他色素沉着的改变。我们报告了一个13个月大的女孩,由于Desmoplastic Medulloblastoma和醒目的皮肤色素沉着,其中包括多个Cafe-Au-Lait Macules,低分成的地区和蒙古斑点而涉及CMMRD。全面测序显示MSH2变体p的纯合子。(LEU92VAL)和MSH6变体P.(VAL809DEL),既有不确定意义(VUS)的变体。肿瘤组织的免疫组织化学分析显示出所有四种MMR蛋白和GMSI检测的表达为阴性。然而,功能测定证明患者的细胞显示甲基化耐受性和离体微卫星不稳定性,其明确证实了CMMRD的诊断。连同,结果使MSH2变异不太可能对表型负责,而它们与MSH6相关的CMMRD兼容。这种情况说明了在VUS患者中确认CMMRD综合征的诊断策略。

著录项

  • 来源
  • 作者单位

    Heinrich Heine Univ Univ Childrens Hosp Dept Paediat Oncol Haematol &

    Clin Immunol Med Fac;

    Med Univ Innsbruck Div Human Genet Innsbruck Austria;

    UPMC Univ Paris 06 Sorbonne Univ INSERM CNRS CRSA F-75012 Paris France;

    UPMC Univ Paris 06 Sorbonne Univ INSERM CNRS CRSA F-75012 Paris France;

    UPMC Univ Paris 06 Sorbonne Univ INSERM CNRS CRSA F-75012 Paris France;

    Med Univ Innsbruck Div Human Genet Innsbruck Austria;

    Heinrich Heine Univ Univ Childrens Hosp Dept Paediat Oncol Haematol &

    Clin Immunol Med Fac;

    Heinrich Heine Univ Med Fac Dept Neuropathol Dusseldorf Germany;

    Heinrich Heine Univ Med Fac Inst Pathol Dusseldorf Germany;

    Heinrich Heine Univ Univ Childrens Hosp Dept Paediat Oncol Haematol &

    Clin Immunol Med Fac;

    Heinrich Heine Univ Univ Childrens Hosp Dept Paediat Oncol Haematol &

    Clin Immunol Med Fac;

    Heinrich Heine Univ Univ Childrens Hosp Dept Paediat Oncol Haematol &

    Clin Immunol Med Fac;

    Heinrich Heine Univ Univ Childrens Hosp Dept Paediat Oncol Haematol &

    Clin Immunol Med Fac;

    Heinrich Heine Univ Univ Childrens Hosp Dept Paediat Oncol Haematol &

    Clin Immunol Med Fac;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号